Nutrition and Dietetics, Internal Medicine, Oncology, Gastroenterology
34
Scopus Publications
Scopus Publications
Harnessing the gut microbiota in extra-intestinal cancers: from causal evidence to immunotherapy strategies Elisa Mattavelli, Valentina Da Prat, Salvatore Corallo, Alice Tartara, Simone Figini, Francesca De Simeis, Sofia Marino, Anna Uggè, Riccardo Caccialanza, Paolo Pedrazzoli, Angioletta Lasagna Immunotherapy, 2026 The gut microbiota (GM) has emerged as a key modulator of cancer development and therapeutic response beyond the gastrointestinal tract. In extra-intestinal cancers, GM composition influences oncogenesis, with specific microbial taxa and their metabolites linked to either increased or decreased cancer risk, as highlighted by Mendelian Randomization studies. Beyond cancer initiation, GM plays a critical role in shaping the efficacy and toxicity of anticancer therapies, particularly immunotherapy. We searched PubMed and ClinicalTrials.gov using the terms“gut microbiota,” “immune checkpoint inhibitors,” “faecal microbiota transplantation,” “solid tumor” in oncology patients. Evidence indicates that SCFA-producing bacteria, Akkermansia muciniphila, and members of Lachnospiraceae and Ruminococcaceae families enhance responses to immune checkpoint inhibitors (ICIs), whereas dysbiosis and immunosuppressive bacteria are associated with poor outcomes and immune-related adverse events. Therapeutic modulation of the GM through probiotics, prebiotics, fecal microbiota transplantation, and dietary interventions shows promise in optimizing immunotherapy efficacy, yet standardized clinical protocols remain lacking. Integrating GM profiling with multi-omics and artificial intelligence approaches offers a path toward personalized microbiota-targeted interventions to improve patient outcomes. This review critically summarizes current evidence linking GM to cancer immunotherapy, discusses mechanistic insights, and outlines future perspectives for translating microbiota modulation into clinical practice.
Nutritional Support via Jejunostomy Placed During Staging Laparoscopy for Esophagogastric Cancer: A Case Series Maria Tieri, Claudia Sivieri, Jacopo Viganò, Salvatore Corallo, Andrea Dagnoni, Anna Pagani, Elisa Mattavelli, Anna Uggè, Francesca De Simeis, Alice Tartara, Paolo Pedrazzoli, Riccardo Caccialanza, Valentina Da Prat Healthcare Switzerland, 2026 Background: Malnutrition is associated with poorer clinical outcomes in esophagogastric cancers (EGCs). Enteral nutrition via feeding jejunostomy (FJ) is feasible and effective, although standardized criteria for its placement during staging laparoscopy (SL) are lacking. Here, we describe a case series with the aim of generate preliminary evidence in highlighting unmet needs in this setting. Methods: We retrospectively reviewed medical records of EGC patients who underwent FJ placement during SL at the Fondazione IRCCS Policlinico S. Matteo from January 2022 to December 2023. Patients with missing nutritional data or known metastatic disease were excluded. Results: We included 14 Caucasian patients aged 66 years (IQR: 56.3–69.5) with a median Body Mass Index (BMI) of 23.7 kg/m2 (IQR: 21.6–26.3). The tumor location was the gastroesophageal junction in eight cases (57%), the body of the stomach in four cases (29%), and the esophagus in two cases (14%). At the time of diagnosis, all patients had experienced weight loss: 13.4% of body weight (IQR: 8.7–16.8) in the last 6 months; with high malnutrition risk scores: NRS-2002 = 3 (IQR: 2–4) and MUST = 2 (IQR: 1–2). Prior to FJ placement only four (29%) patients had tried oral nutrition supplements (ONS) and nine (64%) had been evaluated by dietitians. Home enteral nutrition (HEN) was started in twelve (86%) cases, with three (21%) providing total enteral nutrition and 9 (64%) as supplemental HEN, providing a median of 45.5% of energy needs (IQR: 32.6–68.2). Due to sufficient oral intake, HEN was not started in two cases (14%) and was discontinued in the first month in another two cases. In this series, FJ was in place but unused for a median duration of 11 days (IQR: 3–91). The median duration of HEN was 97 days (IQR: 40–135); with 5 (35%) patients achieving weight stability/gain. FJ-related complications requiring hospitalization occurred in three (21%) cases. Conclusions: In this case series, we observed a suboptimal utilization of the FJ. Several patients had not undergone ONS trials or dietitian assessment prior to FJ placement, while others retained the FJ for months without using it. Given the potential risks of FJ, standardized selection criteria are warranted; routine preoperative nutritional assessments before SL should be implemented to identify high-risk patients and optimize FJ placement.
Toward a Pragmatic Multidisciplinary Management of Nutritional Risk in Hospitalized Patients: Initiatives and Proposals of the Clinical Nutrition Network of Lombardy Region Elisa Mattavelli, Elvira Verduci, Annalisa Mascheroni, Ettore Corradi, Valentina Da Prat, Emanuela Ammoni, Danilo Cereda, Alessandro Scardoni, Alessandro Amorosi, Riccardo Caccialanza Nutrients, 2025 Malnutrition is a widespread problem in hospitalized patients, which significantly impacts clinical outcomes, quality of life, and healthcare costs. Despite its well-documented consequences, it remains underdiagnosed and inadequately managed in many healthcare settings. Even with recent progress, key challenges remain, including inconsistent use of standardized nutritional screening tools and practices, insufficient professional training, and resource limitations. A multidisciplinary approach involving physicians, dietitians, nurses, and pharmacists is crucial for early detection, timely intervention, and prevention of malnutrition-related complications. The sustainability of a multidisciplinary model requires overcoming logistical and financial barriers, including the integration of technology for real-time monitoring, standardized screening protocols, and specific professional training. Regional initiatives, such as the establishment of the Clinical Nutrition Network of Lombardy (Italy), reported and discussed in this article, have made strides in improving nutritional care by promoting scientific networking and standardized practices across hospitals. This approach may not only improve patient outcomes but also reduce long-term healthcare costs by shortening hospital stays and preventing readmissions. For this model to be effective and sustainable, collaboration among healthcare providers, policymakers, and researchers is essential to promote an integrated, cost-effective approach to managing nutritional risk throughout the continuum of care.
Parenteral lipid emulsions: The state of the art Valentina Da Prat, Riccardo Caccialanza, Paolo Cotogni Current Opinion in Clinical Nutrition and Metabolic Care, 2025 Purpose of review Several types of injectable lipid emulsions (ILEs) have become available for parenteral nutrition. The purpose of this review is to highlight the most recent and interesting articles in the field of ILEs. Recent findings Recent literature has compared ILEs in various clinical scenarios (e.g. abdominal surgery, chronic intestinal failure, critical illness, and preterm birth). Favorable clinical effects of ILEs containing fish oil have been observed in studies on surgical patients with Crohn's disease, critically ill patients, and patients with intestinal failure-associated liver dysfunction, whereas other trials have shown no clear benefit. Ongoing research is focused on finding novel strategies to reduce liver toxicity of ILEs, including the use of ‘artificial intelligence’ tools and liver organoids. Promising new applications for ILEs are emerging, including the prevention of neonatal hypoxic brain injury. Summary Although ILEs with the goal of reducing the levels of pro-inflammatory omega-6 fatty acids appear to confer some advantage in some settings (e.g. surgery), conclusive data on the superiority of one ILE over another are lacking. In particular, research is needed to compare different types of mixed-oil ILEs with each other and with pure fish oil ILEs.
Effect of Perioperative Immunonutrition on Early-Postoperative Complications in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Case Series Francesco Cianflone, Alice Tartara, Lucia Aretano, Valentina Da Prat, Andrea Ringressi, Carlo Marchetti, Chiara Lonati, Giulia Gambini, Riccardo Caccialanza, Richard Naspro Journal of Clinical Medicine, 2025 Objective: The objective was to evaluate the impact of perioperative immunonutrition (IN) on postoperative complications in patients undergoing radical cystectomy (RC) for bladder cancer (BC). Methods: A prospective case series of 19 patients treated with perioperative IN between October 2022 and July 2023 was conducted. Patients received preoperative IN based on nutritional risk and postoperative IN with gradual recovery of normal feeding. The inclusion criteria encompassed clinically node-negative patients without metastatic disease. The outcomes were assessed using Clavien–Dindo classification and included infectious complications, wound healing disorders, ileus, anemia, genitourinary issues, recovery time, and compliance with the nutritional regimen. Results: Sixteen patients (84.2%) experienced complications. Most were low-grade (CD 1–2), with no CD > 3a. Wound disorders affected 10.5% and anemia requiring transfusion occurred in 47.4% of patients, infectious complications were reported in 26.3%, and ileus in 36.8%. The median time to first flatus was 2 days (IQR 2–3), while resumption of oral feeding occurred after 4 days (IQR 2–5), like mobilization (IQR 2–5). The median hospital stay was 14 days (IQR 11–18). Compliance with IN was 78.9%, with gastrointestinal intolerance being the primary cause of discontinuation. Conclusions: Patients with RC undergoing perioperative IN showed low rates of high-grade complications and promising results in bowel function recovery and infection rates. Further randomized controlled trials are required to validate these results.
Nutritional status, immunonutrition, and gut microbiome: a coming of age for immunotherapy? Elisa Mattavelli, Francesco Agustoni, Alice Tartara, Francesca De Simeis, Lorenzo Perrone, Riccardo Caccialanza, Paolo Pedrazzoli, Valentina Da Prat Frontiers in Immunology, 2025 In the last decades, immunotherapy has revolutionized cancer treatment. Despite its success, a significant number of patients fail to respond, and the underlying causes of ineffectiveness remain poorly understood. Factors such as nutritional status and body composition are emerging as key predictors of immunotherapy outcomes. In particular, poor nutritional status, sarcopenia, and low skeletal muscle mass are associated with poorer survival and immunotherapy response in several cancers. Conversely, certain parameters of body composition, such as adiposity, may have beneficial effects on immunotherapy efficacy. Nutritional status and body composition can be targeted through tailored nutritional support, making it a potential strategy to improve immunotherapy outcomes. Specific nutrients and modulation of the gut microbiota may further enhance immune functions, offering promising avenues for clinical improvement. Despite the promising potential of tailored nutritional support, clinical evidence remains limited, and further research is needed to establish optimal strategies to optimize immunotherapy response and effectiveness.
Supportive care for systemic amyloidosis: International Society of Amyloidosis (ISA) expert panel guidelines Eli Muchtar, Martha Grogan, Fabian aus dem Siepen, Marcia Waddington-Cruz, Yohei Misumi, Antonia S. Carroll, John O. Clarke, Vaishali Sanchorawala, Paolo Milani, Riccardo Caccialanza, Valentina Da Prat, Rajiv Pruthi, Luis F. Quintana, Frank Bridoux Amyloid, 2025 Systemic amyloidosis refers to a group of protein misfolding disorders resulting in organ deposition with amyloid, leading to organ dysfunction, ultimately resulting in organ failure and death if not successfully treated. Treatment is type-specific and aimed at the underlying source of the misfolded protein. In the past decades, treatments have become increasingly available across the various amyloidosis types with improved response rates and longer survival. Supportive care measures are an integral part of care for patients with systemic amyloidosis to improve symptom burden and quality of life, reduce healthcare costs, and potentially prolong survival while type-directed therapy takes effect. In these guidelines, we provide supportive care recommendations across eight areas of interest in systemic amyloidosis: cardiology, nephrology, peripheral neuropathy, central nervous system involvement, autonomic neuropathy, gastroenterology, coagulopathy and bleeding, nutrition and hematology. These guidelines were developed on behalf of the International Society of Amyloidosis (ISA) by experts in the above fields and provide the best available evidence and expertise for supportive care in these rare disorders.
Anticancer restrictive diets and the risk of psychological distress: Review and perspectives Valentina Da Prat, Gabriella Pravettoni, Amanda Casirati, Chiara Marzorati, Paolo Pedrazzoli, Riccardo Caccialanza Cancer Medicine, 2024 IntroductionThe most studied anticancer restrictive diets include fasting, fasting‐mimicking diets (FMDs) and ketogenic diets (KDs). Besides the current lack of established clinical benefit and the significant risk of malnutrition and micronutrient deficiencies, dietary restrictions in cancer patients might have relevant psychological effects.Materials and MethodsWe reviewed the randomized and non‐randomized controlled clinical trials (CCTs) reporting data on the psychological impact of fasting, FMDs and KDs in cancer patients. We excluded trials on restrictive diets performed for weight reduction in obese or overweight patients, studies on dietary restrictions lasting less than 24 h, and studies on fasting related to cultural or religious beliefs.ResultsThree CCTs on fasting or FMDs and eight CCTs on KDs in cancer patients were included. In terms of diet‐related distress, emotional, social, and family well‐being, none of these studies showed a detrimental impact of fasting, FMDs and KDs. However, clinical trials specifically assessing the psychological aspects in the long term are lacking.Conclusions and PerspectivesIn the absence of a conclusive evidence on the clinical benefits of restrictive diets, which carry significant risks especially if unsupervised, further studies are needed to clarify their psychological impact in cancer patients. Multidisciplinary approaches including psychological evaluations should be used to ameliorate patient selection for clinical trials, identify early distress symptoms, and increase patient compliance to dietary recommendations.
Two-year multidisciplinary follow-up of COVID-19 patients requiring invasive and noninvasive respiratory support Moreno TRESOLDI, Alberto ZANGRILLO, Alessandro BELLETTI, Giuseppe A. RAMIREZ, Enrica BOZZOLO, Francesca GUZZO, Alessandro MARINOSCI, Evgeny V. FOMINSKIY, Valentina DA PRAT, Marilena MARMIERE, Diego PALUMBO, Lidia DEL PRETE, Filippo D’AMICO, Chiara BELLINO, Deodata MORANDO, Marco SARACINO, Alessandro ORTALDA, Elena CASTELLI, Margherita ROCCHI, Martina BAIARDO REDAELLI, Raffaella SCOTTI, Gaetano DI TERLIZZI, Maria L. AZZOLINI, Giulia GUASCHINO, Emma AVITABILE, Giovanni BORGHI, Daniele SODDU, Lorenzo DAGNA, Giovanni LANDONI, Francesco DE COBELLI, and Minerva Medica, 2023
Immunonutrition in Radical Cystectomy: State of the Art and Perspectives Amanda Casirati, Valentina Da Prat, Arianna Bettiga, Lucia Aretano, Francesco Trevisani, Emanuele Cereda, Alberto Briganti, Elisa Colombo, Giorgia Preziati, Francesca De Simeis, Andrea Salonia, Francesco Montorsi, Riccardo Caccialanza, Richard Naspro Cancers, 2023
Outcomes of noninvasive ventilation as the ceiling of treatment in patients with COVID-19 Giuseppe A. RAMIREZ, Enrica P. BOZZOLO, Agnese GOBBI, Elena CASTELLI, Clarissa CENTURIONI, Mattia DI MEO, Emanuel DELLA TORRE, Flavia DI SCALA, Anna MORGILLO, Alessandro MARINOSCI, Martina MIGLIO, Paolo SCARPELLINI, Chiara TASSAN DIN, Barbara CASTIGLIONI, Chiara OLTOLINI, Marco RIPA, Gaetano DI TERLIZZI, Valentina DA PRAT, Sarah DAMANTI, Raffaella SCOTTI, Giuseppe DI LUCCA, Martina BAIARDO REDAELLI, Valentina P. PLUMARI, Elena MOIZO, Francesco CARCÓ, Paolo SILVANI, Francesco DE COBELLI, Giovanni LANDONI, Moreno TRESOLDI, and Panminerva Medica, 2022
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 Marco Ripa, Laura Galli, Armando D’Angelo, Luca Apruzzi, Diego Palumbo, Corrado Campochiaro, Chiara Tassan Din, Anna Danise, Valentina Da Prat, Giordano Vitali, Luigia Brugliera, Andrea Poli, Roberta Monardo, Giacomo Monti, Domenico Baccellieri, Francesco De Cobelli, Massimo Clementi, Sandro Iannaccone, Lorenzo Dagna, Patrizia Rovere-Querini, Fabio Ciceri, Moreno Tresoldi, Alberto Zangrillo, Paolo Scarpellini, Antonella Castagna, Andrea Andolina, Alba Bigoloni, Simona Bossolasco, Elena Bruzzesi, Diana Canetti, Barbara Castiglioni, Massimo Cernuschi, Matteo Chiurlo, Paola Cinque, Raffaele Dell’Acqua, Liviana Della Torre, Nicola Gianotti, Monica Guffanti, Hamid Hasson, Emanuela Messina, Giulia Morsica, Silvia Nozza, Martina Ranzenigo, Caterina Uberti-Foppa, Concetta Vinci, Flavia Badalucco Ciotta, Martina Bottanelli, Tommaso Clemente, Ilaria Mainardi, Giovanni Mori, Rebecka Papaioannu Borjesson, Giacomo Ponta, Camilla Muccini, Andrea Mastrangelo, Chiara Oltolini, Vincenzo Spagnuolo, Luca Benassi, Giorgia Bigai, Enrica Bozzolo, Giorgia Borio, Cecilia Bussolari, Stefania Calvisi, Valentina Canti, Jacopo Castellani, Ludovica Cavallo, Marta Cilla, Elena Cinel, Nicola Compagnone, Teresa D’Aliberti, Sarah Damanti, Rebecca De Lorenzo, Giuseppe Di Lucca, Gaetano Di Terlizzi, Iulia Dumea, Federica Farolfi, Marica Ferrante, Claudia Frangi, Gabriele Gallina, Nicolò Germinario Bruno, Marco Lanzillotta, Raffaele Li Voti, Alessandro Marinosci, Sabina Martinenghi, Massimo Memoli, Marco Montagna, Maria Pascali, Alessandro Patrizi, Chiara Pomaranzi, Raffaella Scotti, Silvia Strada, Nicola Boffini, Giulio Cavalli, Emanuel Della Torre, Giacomo De Luca, Nicola Farina, Luca Moroni, Alvise Ramirez Giuseppe, Alessandro Tomelleri, Luisa Azzolini Maria, Martina Baiardo Redaelli, Grazia Calabrò Maria, Maria Casiraghi Giuseppina, Antonio Dell’Acqua, Stefano Fresilli, Francesca Guzzo, Giovanni Landoni, Gaetano Lombardi, Nicolò Maimeri, Elena Moizo, Giuseppe Nisi Francesco, Alessandro Oriani, Alessandro Ortalda, Nicola Pasculli, Marina Pieri, Stefano Turi, Luca Bertoglio, Victor Bilman, Silvia Carletti, Floriana Gona, Nicasio Mancini, Patrizia Della Valle, Chiara Molinari, Antonella Poloniato, Francesca Lalla, Dario Prestifilippo, Jacopo Sapienza, Federico Seghi, and Open Forum Infectious Diseases, 2022
A novel evidence-based algorithm to predict thromboembolism in patients with COVID-19: preliminary data from a single-center cohort Giuseppe A. RAMIREZ, Stefania L. CALVISI, Rebecca DE LORENZO, Valentina DA PRAT, Giorgia BORIO, Gabriele GALLINA, Federica FAROLFI, Ludovica CAVALLO, Maria PASCALI, Jacopo CASTELLANI, Domenico BACCELLIERI, Francesca GUZZO, Martina BAIARDO REDAELLI, Maria L. AZZOLINI, Ada C. ALBA, Alberto ZANGRILLO, Enrica P. BOZZOLO, Raffaella SCOTTI, Giuseppe DI LUCCA, Lorenzo PIEMONTI, Patrizia ROVERE QUERINI, Armando D’ANGELO, Moreno TRESOLDI, and Minerva Medica, 2022
Frailty as a predictor of mortality in COVID-19 patients receiving CPAP for respiratory insufficiency Sarah Damanti, Giuseppe Alvise Ramirez, Enrica Paola Bozzolo, Valentina Da Prat, Giuseppe Di Lucca, Gaetano Di Terlizzi, Alessandro Marinosci, Raffaella Scotti, Silvia Strada, Paolo Scarpellini, Barbara Castiglioni, Chiara Oltolini, Marco Ripa, Chiara Tassan Din, Clarissa Elisabeth Centurioni, Flavia Di Scala, Agnese Gobbi, Ada Carla Alba, Giuseppina Maria Casiraghi, Anna Morgillo, Moreno Tresoldi Aging Clinical and Experimental Research, 2022
QTc interval prolongation, inflammation, and mortality in patients with COVID-19 Simone Gulletta, Paolo Della Bella, Luigi Pannone, Giulio Falasconi, Lorenzo Cianfanelli, Savino Altizio, Elena Cinel, Valentina Da Prat, Antonio Napolano, Giuseppe D’Angelo, Luigia Brugliera, Eustachio Agricola, Giovanni Landoni, Moreno Tresoldi, Patrizia Querini Rovere, Fabio Ciceri, Alberto Zangrillo, Pasquale Vergara Journal of Interventional Cardiac Electrophysiology, 2022
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) V. Spagnuolo, M. Guffanti, L. Galli, A. Poli, P. Rovere Querini, M. Ripa, M. Clementi, P. Scarpellini, A. Lazzarin, M. Tresoldi, L. Dagna, A. Zangrillo, F. Ciceri, A. Castagna, A. Andolina, M. Baiardo Redaelli, E. Baldissera, G. Bigai, A. Bigoloni, N. Boffini, G. Borio, S. Bossolasco, E. Bruzzesi, M. G. Calabrò, S. Calvisi, C. Campochiaro, D. Canetti, V. Canti, J. Castellani, B. Castiglioni, G. Cavalli, L. Cavallo, M. Cernuschi, M. Chiurlo, M. Cilla, E. Cinel, P. Cinque, C. Conte, V. Da Prat, A. Danise, R. De Lorenzo, G. De Luca, A. Dell’Acqua, R. Dell’Acqua, Emanuel Della-Torre, L. Della Torre, G. Di Terlizzi, I. Dumea, F. Farolfi, M. Ferrante, C. Frangi, L. Fumagalli, G. Gallina, B. Germinario, N. Gianotti, H. Hasson, F. Lalla, G. Landoni, M. Lanzillotta, R. Li Voti, A. Mastrangelo, E. Messina, E. Moizo, M. Montagna, G. Monti, G. Morsica, C. Muccini, S. Nozza, C. Oltolini, M. Pascali, A. Patrizi, M. Pieri, D. Prestifilippo, G. Ramirez, M. Ranzenigo, J. Sapienza, S. Sartorelli, F. Seghi, G. Tambussi, C. Tassan Din, A. Tomelleri, S. Turi, C. Uberti-Foppa, C. Vinci, and Scientific Reports, 2021
Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19: Thromboembolism, diabetes and COVID-19 Stefania L. Calvisi, Giuseppe A. Ramirez, Marina Scavini, Valentina Da Prat, Giuseppe Di Lucca, Andrea Laurenzi, Gabriele Gallina, Ludovica Cavallo, Giorgia Borio, Federica Farolfi, Maria Pascali, Jacopo Castellani, Vito Lampasona, Armando D'Angelo, Giovanni Landoni, Fabio Ciceri, Patrizia Rovere Querini, Moreno Tresoldi, Lorenzo Piemonti Metabolism Clinical and Experimental, 2021
Two-months quality of life of COVID-19 invasively ventilated survivors; an Italian single-center study Giacomo Monti, Carlo Leggieri, Evgeny Fominskiy, Anna Mara Scandroglio, Sergio Colombo, Margherita Tozzi, Elena Moizo, Milena Mucci, Martina Crivellari, Marina Pieri, Francesca Guzzo, Simona Piemontese, Rebecca De Lorenzo, Valentina Da Prat, Monica Fedrizzi, Carolina Faustini, Martina Di Piazza, Francesca Conte, Rosalba Lembo, Antonio Esposito, Lorenzo Dagna, Giovanni Landoni, Alberto Zangrillo Acta Anaesthesiologica Scandinavica, 2021
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors Marco Ripa, Laura Galli, Andrea Poli, Chiara Oltolini, Vincenzo Spagnuolo, Andrea Mastrangelo, Camilla Muccini, Giacomo Monti, Giacomo De Luca, Giovanni Landoni, Lorenzo Dagna, Massimo Clementi, Patrizia Rovere Querini, Fabio Ciceri, Moreno Tresoldi, Adriano Lazzarin, Alberto Zangrillo, Paolo Scarpellini, Antonella Castagna, Andrea Andolina, Martina Baiardo Redaelli, Giorgia Bigai, Alba Bigoloni, Giorgia Borio, Simona Bossolasco, Elena Bruzzesi, Maria Grazia Calabrò, Stefania Calvisi, Corrado Campochiaro, Diana Canetti, Valentina Canti, Jacopo Castellani, Barbara Castiglioni, Giulio Cavalli, Ludovica Cavallo, Massimo Cernuschi, Matteo Chiurlo, Marta Cilla, Elena Cinel, Paola Cinque, Caterina Conte, Valentina Da Prat, Anna Danise, Rebecca De Lorenzo, Antonio Dell’Acqua, Raffaele Dell’Acqua, Emanuel Della Torre, Liviana Della Torre, Gaetano Di Terlizzi, Iulia Dumea, Federica Farolfi, Marica Ferrante, Claudia Frangi, Luca Fumagalli, Gabriele Gallina, Bruno Germinario, Nicola Gianotti, Monica Guffanti, Hamid Hasson, Francesca Lalla, Marco Lanzillotta, Raffaele Li Voti, Emanuela Messina, Chiara Molinari, Elena Moizo, Marco Montagna, Giulia Morsica, Silvia Nozza, Maria Pascali, Alessandro Patrizi, Marina Pieri, Antonella Poloniato, Dario Prestifilippo, Giuseppe Ramirez, Martina Ranzenigo, Jacopo Sapienza, Federico Seghi, Giuseppe Tambussi, Chiara Tassan Din, Stefano Turi, Caterina Uberti-Foppa, Concetta Vinci Clinical Microbiology and Infection, 2021
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 V. Spagnuolo, M. Guffanti, L. Galli, A. Poli, P. Rovere Querini, M. Ripa, M. Clementi, P. Scarpellini, A. Lazzarin, M. Tresoldi, L. Dagna, A. Zangrillo, F. Ciceri, A. Castagna, A. Andolina, M. Baiardo Redaelli, E. Baldissera, G. Bigai, A. Bigoloni, N. Boffini, G. Borio, S. Bossolasco, E. Bruzzesi, M. G. Calabrò, S. Calvisi, C. Campochiaro, D. Canetti, V. Canti, J. Castellani, B. Castiglioni, G. Cavalli, L. Cavallo, M. Cernuschi, M. Chiurlo, M. Cilla, E. Cinel, P. Cinque, C. Conte, V. Da Prat, A. Danise, R. De Lorenzo, G. De Luca, A. Dell’Acqua, R. Dell’Acqua, E. Della-Torre, L. Della Torre, G. Di Terlizzi, I. Dumea, F. Farolfi, M. Ferrante, C. Frangi, L. Fumagalli, G. Gallina, B. Germinario, N. Gianotti, H. Hasson, F. Lalla, G. Landoni, M. Lanzillotta, R. Li Voti, A. Mastrangelo, E. Messina, E. Moizo, M. Montagna, G. Monti, G. Morsica, C. Muccini, S. Nozza, C. Oltolini, M. Pascali, A. Patrizi, M. Pieri, D. Prestifilippo, G. Ramirez, M. Ranzenigo, J. Sapienza, S. Sartorelli, F. Seghi, G. Tambussi, C. Tassan Din, A. Tomelleri, S. Turi, C. Uberti-Foppa, C. Vinci, and Scientific Reports, 2020
